Show simple item record

Appropriate Serological Testing in Pregnancy

dc.contributor.authorJudd, W. Johnen_US
dc.contributor.authorSteiner, E. Annen_US
dc.contributor.authorNugent, Clark E.en_US
dc.date.accessioned2010-06-01T19:24:58Z
dc.date.available2010-06-01T19:24:58Z
dc.date.issued1992-11en_US
dc.identifier.citationJudd, W. John; Steiner, E. Ann; Nugent, Clark E. (1992). "Appropriate Serological Testing in Pregnancy." Vox Sanguinis 63(4): 293-294. <http://hdl.handle.net/2027.42/72557>en_US
dc.identifier.issn0042-9007en_US
dc.identifier.issn1423-0410en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72557
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1481482&dopt=citationen_US
dc.format.extent198378 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1992 Blackwell Publishing Ltden_US
dc.titleAppropriate Serological Testing in Pregnancyen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Pathology, University of Michigan, Ann Arbor, Mich., USAen_US
dc.contributor.affiliationumObstetrics and Gynecology, University of Michigan, Ann Arbor, Mich., USAen_US
dc.identifier.pmid1481482en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72557/1/j.1423-0410.1992.tb01243.x.pdf
dc.identifier.doi10.1111/j.1423-0410.1992.tb01243.xen_US
dc.identifier.sourceVox Sanguinisen_US
dc.identifier.citedreferenceGarner SF, Devenish A., Barber H., Contreras M.: The importance of monitoring ‘enzyme-only’ red cell antibodies during pregnancy. Vox Sang 1991; 61: 219 – 220.en_US
dc.identifier.citedreferenceJudd WJ, Luban NLC, Ness PM, Silberstein LE, Stroup M., Widmann FK: Prenatal and perinatal immunohematology: Recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990; 30: 175 – 183.en_US
dc.identifier.citedreferenceIssit PD: Lack of clinical significance of ‘enzyme-only’ red cell antibodies. Transfusion 1991; 31 ( S ): 39.en_US
dc.identifier.citedreferenceWalker RH: Relevancy in the selection of serologic tests for the obstetric patient; in Garratty G. ( ed ): Hemolytic Disease of the Newborn. Arlington, American Association of Blood Banks, 1984, pp 173 – 203.en_US
dc.identifier.citedreference5 Management of isoimmunization in pregnancy. Tech Bull No 148. Washington, American College of Obstetricians and Gynecologists, 1990.en_US
dc.identifier.citedreferenceFreda VJ: The antepartum management of hemolytic disease; in Garratty G. ( ed ): Hemolytic Disease of the Newborn. Arlington, American Association of Blood Banks, 1984, pp 33 – 51.en_US
dc.identifier.citedreferenceOberman HA, Judd WJ: Cost-containment in transfusion practice: A view from the United States; in Cash JD ( ed ): Progress in Transfusion Medicine. Edinburgh, Churchill-Livingstone, 1988; vol 3, pp 145 – 174.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.